The bacteria Pseudomonas aeruginosa can cause serious and difficult to treat infections. The infection process involves the activation of toxic substances from the bacteria by a common protein in our cells. Researchers at Karolinska Institutet in Sweden now show how this happens and that the activation can be stopped with drug-like molecules. The results are presented in Nature Communications.